Kobayashi to Launch Bioactive Bone Cement in November

Kobayashi Pharmaceutical has announced that in November it will launch bioactive bone cement developed by NGK Spark Plug. The new product, which is to be provided in a pre-filled syringe, when applied, hardens and transforms into hydroxyapatite (HAp) in the body, and promotes bone formation.

()a href="http://www.japancorp.net/Article.asp?Art_ID=10315" target="_blank">Japan Corporate News